SAUNDERS BRENT L
Transactions
50
Companies
8
Filings
11
CIK
0001268854
Recent Transactions
- Tax Payment
- Award
- Award
- Award
- Award
- Purchase
- Exercise/Conversion
- Exercise/Conversion
- Sale
- Award
- AwardBausch & Lomb Corp$BLCO
Non-Qualified Stock Options (right to purchase)
2025-02-26+600,858→ 600,858 total - Tax Payment
- Tax Payment
- Purchase
- Purchase
- Award
- Award
- Award
- AwardBausch & Lomb Corp$BLCO
Non-Qualified Stock Options (right to purchase)
2024-02-28+569,105→ 569,105 total - Award
- Purchase
- Award
- Award
- Tax Payment
- Tax Payment
- Award
- Award
- Award
- Tax Payment
- Tax Payment
- Award
- Tax Payment
- Award
- Award
- Tax Payment
- Purchase
- Award
- Award
- Award
- Award
- Other
- Other
- Award
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Award
- Disposition to Issuer
- Disposition to Issuer
Companies
8Allergan plc
Director, CEO and President
- $SPRY
ARS Pharmaceuticals, Inc.
Director
- $BLCO
Bausch & Lomb Corp
Director, CEO and Chairman of the Board
- $SKIN
Beauty Health Co
Director, Chairman
- $BBIO
BridgeBio Pharma, Inc.
Director
- $CSCO
CISCO SYSTEMS, INC.
Director
Forest Laboratories, LLC
Director
- $MRK
Merck & Co., Inc.
Senior Vice President
Recent Filings
11- 4
SAUNDERS BRENT L
Aug 7, 2025
- 4
SAUNDERS BRENT L
Jul 23, 2025
- 4
SAUNDERS BRENT L
Jun 27, 2025
- 4
SAUNDERS BRENT L
Jun 18, 2025
- 4
SAUNDERS BRENT L
May 27, 2025
- 4
SAUNDERS BRENT L
May 22, 2025
- 4
SAUNDERS BRENT L
Feb 28, 2025
- 4
SAUNDERS BRENT L
Dec 26, 2024
- 4
SAUNDERS BRENT L
Aug 13, 2024
- 4
SAUNDERS BRENT L
Aug 7, 2024
- 4
SAUNDERS BRENT L
Jul 10, 2024
Address
SCHERING-PLOUGH CORPORATION 2000 GALLOPING HILL ROAD
KENILWORTH, NJ, 07033